跳至主要内容
临床试验/CTRI/2025/12/099584
CTRI/2025/12/099584尚未招募不适用

Effect of an Integrated Yoga Module on Mental Health and Quality of Life in Cancer Patients: A Randomized Controlled Trial

University of Patanjali1 个研究点 分布在 1 个国家目标入组 136 人开始时间: 2026年1月6日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
136
试验地点
1
主要终点
Anxiety, Depression, Quality of Sleep, Cognitive Emotion Regulation Questionnaire, Quality of Life

研究概览

简要总结

This research examines how a structured yoga program can help cancer patients manage psychological stress during chemotherapy. Cancer patients often face significant anxiety, depression, sleep problems, and difficulty coping with their emotions while receiving treatment. Current approaches mainly use medications, which can cause additional side effects and dependency issues.

Our study offers a 12-week integrated yoga program specifically designed for patients undergoing active chemotherapy. The program combines gentle physical postures, breathing exercises, meditation, and mindfulness practices adapted to suit the physical limitations and needs of cancer patients. We aim to see whether this yoga intervention can meaningfully reduce anxiety and depression, improve sleep quality, enhance emotional coping skills, and boost overall quality of life.

The study will enroll 136 cancer patients from various cancer types who are currently receiving chemotherapy. Participants will be randomly assigned to either receive the yoga program immediately or continue with usual care and receive yoga after the study ends. We will measure changes in mental health, sleep, emotion regulation, and quality of life at the beginning and after 12 weeks.

This research addresses a critical gap because most previous studies focused only on breast cancer survivors after treatment ended, not on diverse cancer patients during the challenging active treatment phase. By understanding how yoga helps patients cope during chemotherapy, we hope to provide evidence-based support that can be integrated into routine cancer care to improve patients’ well-being alongside their medical treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
50.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed with solid tumor malignancy Currently receiving chemotherapy treatment Life expectancy less then equals to 6 months Able to provide informed consent.

排除标准

  • 未提供

结局指标

主要结局

Anxiety, Depression, Quality of Sleep, Cognitive Emotion Regulation Questionnaire, Quality of Life

时间窗: Pre-Data: January | Post-Data: April

次要结局

未报告次要终点

研究者

申办方类型
Other [university]
责任方
Principal Investigator
主要研究者

Ishani

University of Patanjali

研究点 (1)

Loading locations...

相似试验